NEW YORK (GenomeWeb) – The China Food and Drug Administration has approved Agilent Technologies' SureScan Dx microarray scanner for in vitro diagnostic use, the company announced today. 

The scanner is also CE marked for in vitro diagnostic use in Europe and approved for in vitro diagnostic use in South Korea and Singapore. It measures fluorescence signals from labeled DNA and RNA targets hybridized to microarrays, for example, to compare DNA samples, Agilent said. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.